Market Closed -
Other stock markets
|
After market 07:59:42 pm | |||
40.49 USD | -1.82% | 40.52 | +0.07% |
May. 28 | Prothena to Receive $80 Million From Bristol-Myers Squibb For PRX019 Global License | MT |
May. 27 | Bristol Myers: will present data on schizophrenia | CF |
Official Publications
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
Dividends | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
Slide show half-year results | CO | |
1st-half-year results | CO | |
SEC Filing 10Q-2 | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Official Publications